Floyd Robert Michael 4/A
4/A · Processa Pharmaceuticals, Inc. · Filed Jan 6, 2022
Insider Transaction Report
Form 4/AAmended
Floyd Robert Michael
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2021-12-31+6,722→ 22,780 totalExercise: $0.00→ Common Stock (6,722 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.
- [F2]This Amendment is being filed to correct the balance in Box 9 - this should have reflected a cumulative balance.